These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24724444)

  • 41. Rocuronium--onset times and intubating conditions.
    Feldman SA
    Eur J Anaesthesiol Suppl; 1994; 9():49-52. PubMed ID: 7925208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A clinical study of the effects of rocuronium in isoflurane-anaesthetized cats.
    Auer U; Mosing M
    Vet Anaesth Analg; 2006 Jul; 33(4):224-8. PubMed ID: 16764586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness and safety of rocuronium-hypnotic sequence for rapid-sequence induction.
    Chung YT; Yeh LT
    Acta Anaesthesiol Sin; 2001 Mar; 39(1):3-9. PubMed ID: 11407293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of neuromuscular effects, efficacy and safety of rocuronium and atracurium in ambulatory anaesthesia.
    Whalley DG; Maurer WG; Knapik AL; Estafanous FG
    Can J Anaesth; 1998 Oct; 45(10):954-9. PubMed ID: 9836032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potency and recovery characteristics of rocuronium mixed with sodium bicarbonate.
    Lee HJ; Kim KS; Yeon JT; Suh JK; Sung IH; Shin IC
    Anaesthesia; 2010 Sep; 65(9):899-903. PubMed ID: 20608923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid-sequence orotracheal intubation with rocuronium: a randomized double-blind comparison with suxamethonium--preliminary communication.
    Tryba M; Zorn A; Thole H; Zenz M
    Eur J Anaesthesiol Suppl; 1994; 9():44-8. PubMed ID: 7925207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case report: Neuromuscular block induced by rocuronium following sugammadex administration.
    Askin T; Unver S; Oguz D; Kutay K
    J Clin Anesth; 2017 Feb; 37():166-167. PubMed ID: 28235515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients.
    Leykin Y; Pellis T; Lucca M; Lomangino G; Marzano B; Gullo A
    Anesth Analg; 2004 Oct; 99(4):1086-1089. PubMed ID: 15385355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose requirements of alfentanil to eliminate autonomic responses during rapid-sequence induction with thiopental 4 mg/kg and rocuronium 0.6 mg/kg.
    Abou-Arab MH; Rostrup M; Heier T
    J Clin Anesth; 2016 Dec; 35():465-474. PubMed ID: 27871575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
    Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
    Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight?
    Meyhoff CS; Lund J; Jenstrup MT; Claudius C; Sørensen AM; Viby-Mogensen J; Rasmussen LS
    Anesth Analg; 2009 Sep; 109(3):787-92. PubMed ID: 19690247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of etomidate and thiopental on the onset of rocuronium action].
    Muñoz Letelier H; González Arellano A; Dagnino Sepúlveda J; González Sotomayor J
    Rev Esp Anestesiol Reanim; 1999; 46(6):252-5. PubMed ID: 10439645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
    Wulf H; Ledowski T; Linstedt U; Proppe D; Sitzlack D
    Can J Anaesth; 1998 Jun; 45(6):526-32. PubMed ID: 9669005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prolonged apnea from rocuronium in a patient with hypermagnesemia after cesarean section: a case report].
    Funai Y; Ikeda Y; Takahashi R; Asada A
    Masui; 2010 Jun; 59(6):721-3. PubMed ID: 20560373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of magnesium sulphate on intubating condition for rapid-sequence intubation: a randomized controlled trial.
    Kim MH; Oh AY; Han SH; Kim JH; Hwang JW; Jeon YT
    J Clin Anesth; 2015 Nov; 27(7):595-601. PubMed ID: 26315876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Rocuronium (esmerone) in anesthesia during surgery under extracorporeal circulation].
    Kozlov IA; Vershuta DV; Ermolenko AE; Il'nitskiĭ VV; Chernov VA
    Anesteziol Reanimatol; 2002; (5):30-3. PubMed ID: 12611297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The importance of myorelaxants in anesthesia.
    Flood P
    Curr Opin Pharmacol; 2005 Jun; 5(3):322-7. PubMed ID: 15907920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rocuronium for muscle relaxation in two children with Friedreich's ataxia.
    Schmitt HJ; Wick S; Münster T
    Br J Anaesth; 2004 Apr; 92(4):592-6. PubMed ID: 14977802
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.